Translational Development Acquisition Corp.
- TDAC
- NASDAQ
- Shell Companies
- SPAC/Blank Check
$10.81
Today −0.16%Quote Oct 19, 2026, 08:00 PM UTC
Limited analysis: bank-specific metrics are not in this version yet. Debt, free-cash-flow and generic valuation ratios are hidden for this company.
−0.28%over the last month
Max drawdown −0.7%From 1-month high −0.5%3 months +0.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Translational Development Acquisition
Translational Development Acquisition Corp., founded in 2022 and headquartered in New York, New York, currently conducts no significant business operations. Its primary goal is to complete a business combination, such as a merger, amalgamation, share exchange, asset acquisition, share purchase, or reorganization, with one or more companies.
Sector
Financial services
Industry
Shell Companies
Exchange
NASDAQ
Employees
2
Founded
2022
Market value
$182.2M
Approximate share count
Floor
$10.71
0.9% below price
Resistance
$10.86
0.4% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about TDACPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free